title: Nuclear accumulation of expanded PABP2 gene product in oculopharyngeal muscular dystrophy.
abstract: Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease caused by (GCG) repeat expansions in exon 1 of the poly(A) binding protein 2 gene (PABP2). To elucidate the molecular mechanism underlying the disease, we raised an antiserum against a synthetic peptide fragment predicted from PABP2 cDNA. The peptide corresponded to amino acids 271-291 where a cluster of posttranslational arginine methylation occurs. We examined the subcellular localization of PABP2 in muscle specimens from five patients with OPMD, 14 patients with various neuromuscular disorders, and three normal controls. All Japanese patients with OPMD have been shown to have expanded (GCG)(8, 9, or 11) mutations in PABP2, as well as intranuclear tubulofilamentous inclusions (ITFI) of 8.5 nm. None of 50 separate Japanese control individuals were shown to have expanded (GCG) repeat in PABP2. Positive immunoreaction for polyclonal PABP2 was confined to the intranuclear aggregates of muscle fibers exclusively in patients with OPMD. Frequency of the nuclei positive for PABP2 (2%) was similar to that of ITFI detected by electron microscopy (2.5%). There was no apparent relationship between the frequency of PABP2-positive intranuclear aggregates and the severity of muscle fiber damage. In contrast, nuclear immunoreaction was not detected in any samples from normal controls or from other neuromuscular diseases. These results suggest the presence of molecular modification of the product of expanded (GCG) repeat in PABP2, since the synthetic antigen peptide may not recognize a highly dimethylated cluster of arginine residues of the native PABP2, but may recognize the mutated form. Nuclear accumulation of expanded PABP2 product implies a causative role for ITFI.
authors.affiliation: Department of Neurology, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto 860-0811, Japan. uyama@kaiju.medic.kumamotou.ac.jp
authors.forename: E
authors.initials: E
authors.lastname: Uyama
authors.forename: T
authors.initials: T
authors.lastname: Tsukahara
authors.forename: K
authors.initials: K
authors.lastname: Goto
authors.forename: Y
authors.initials: Y
authors.lastname: Kurano
authors.forename: M
authors.initials: M
authors.lastname: Ogawa
authors.forename: Y J
authors.initials: YJ
authors.lastname: Kim
authors.forename: M
authors.initials: M
authors.lastname: Uchino
authors.forename: K
authors.initials: K
authors.lastname: Arahata
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism*; D009136:Muscular Dystrophies / Q000235:genetics* / Q000378:metabolism*; D039103:Poly(A)-Binding Protein II; D018911:Trinucleotide Repeats / Q000235:genetics
chemical_list: D004268:DNA-Binding Proteins; D039103:Poly(A)-Binding Protein II